Patent · US Active

Benzimidazole derivatives

US8431597B2 · kind B2 · utility

15Cited by

2References

1Claims

0Family size

Assignee

PFIZER INC. · US

Inventors

Michael John Munchhof · Corvallis, US
Lawrence Alan Reiter · Mystic, US
Susan D. La Greca · Old Lyme, US
Christopher S. Jones · Gales Ferry, US
Qifang Li · Stonington, US

Key dates

Filing date	Feb 24, 2012
Grant date	Apr 30, 2013
Priority date	—
Expiry date	Mar 5, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D471/04
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present invention relates to a compound of the Formula Ior a pharmaceutically acceptable salt thereof, wherein R1, R2, R3A, R3B, R4, R5, X, m, and n are as defined herein. Such novel benzamidazole derivatives are useful in the treatment of abnormal cell growth, such as cancer, in mammals. This invention also relates to a method of using such compounds in the treatment of abnormal cell growth in mammals, especially humans, and to pharmaceutical compositions containing such compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.